Ye Peng

463 total citations
15 papers, 331 citations indexed

About

Ye Peng is a scholar working on Neurology, Molecular Biology and Surgery. According to data from OpenAlex, Ye Peng has authored 15 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Ye Peng's work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Neuroscience and Neuropharmacology Research (2 papers) and Connexins and lens biology (2 papers). Ye Peng is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Neuroscience and Neuropharmacology Research (2 papers) and Connexins and lens biology (2 papers). Ye Peng collaborates with scholars based in China and Canada. Ye Peng's co-authors include Shifeng Chu, Nai‐Hong Chen, Yingjiao Liu, Xun Li, Xin‐Fu Zhou, Jiao Chen, Zhao Zhang, Songwei Yang, Piao Luo and Siyu Ren and has published in prestigious journals such as International Journal of Molecular Sciences, Spine and Cell Death and Differentiation.

In The Last Decade

Ye Peng

13 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ye Peng China	8	153	68	55	51	37	15	331
Ashi Mannan India	14	194 1.3×	53 0.8×	28 0.5×	82 1.6×	70 1.9×	49	465
Esraa A. Kandil Egypt	12	138 0.9×	46 0.7×	21 0.4×	77 1.5×	70 1.9×	16	363
Anika Sood India	11	135 0.9×	115 1.7×	23 0.4×	64 1.3×	59 1.6×	17	344
Haibiao Guo China	12	238 1.6×	85 1.3×	18 0.3×	82 1.6×	43 1.2×	19	431
Ana Paula Oliveira Ferreira Brazil	12	127 0.8×	58 0.9×	13 0.2×	64 1.3×	46 1.2×	12	420
Alessia Travagli Italy	8	100 0.7×	87 1.3×	37 0.7×	75 1.5×	22 0.6×	13	277
Hyewon Rhim South Korea	12	276 1.8×	54 0.8×	18 0.3×	51 1.0×	85 2.3×	15	400
Xiao Yuan China	12	186 1.2×	49 0.7×	18 0.3×	113 2.2×	30 0.8×	17	477
Xubo Li China	16	194 1.3×	77 1.1×	13 0.2×	108 2.1×	100 2.7×	36	523

Countries citing papers authored by Ye Peng

Since Specialization

Citations

This map shows the geographic impact of Ye Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Peng more than expected).

Fields of papers citing papers by Ye Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Peng. The network helps show where Ye Peng may publish in the future.

Co-authorship network of co-authors of Ye Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Peng. A scholar is included among the top collaborators of Ye Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Peng. Ye Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Peng, Ye, et al.. (2025). Targeting and reprogramming microglial phagocytosis of neutrophils by ginsenoside Rg1 nanovesicles promotes stroke recovery. Bioactive Materials. 47. 181–197. 5 indexed citations

Wang, Hongyun, Ye Peng, Shasha Wang, et al.. (2025). Noncanonical role of astrocytic mitochondrial Cx43: suppressing IDH3α to sustain glycolytic homeostasis against depression. Cell Death and Disease. 17(1). 94–94.

Peng, Ye, et al.. (2025). Hydrogel-based tumor embolization and synergistic therapeutic strategies. Bioactive Materials. 59. 17–44.

Lai, H. K., Hongyun Wang, Shasha Wang, et al.. (2025). CKLF1 disrupts microglial efferocytosis following acute ischemic stroke by binding to phosphatidylserine. Cell Death and Differentiation. 32(8). 1499–1517. 2 indexed citations

Peng, Ye, Xu Yan, Wenbin He, et al.. (2024). Esculetin facilitates post-stroke rehabilitation by inhibiting CKLF1-mediated neutrophil infiltration. Acta Pharmacologica Sinica. 46(1). 52–65. 1 indexed citations

Wang, Hongyun, Ye Peng, Haodong Chen, et al.. (2023). CKLF induces microglial activation via triggering defective mitophagy and mitochondrial dysfunction. Autophagy. 20(3). 590–613. 42 indexed citations

Zhang, Ningning, Hong Jiang, Huiqin Wang, et al.. (2022). Novel Antidepressant Mechanism of Ginsenoside Rg1 in Regulating the Dysfunction of the Glutamatergic System in Astrocytes. International Journal of Molecular Sciences. 24(1). 575–575. 13 indexed citations

Zhu, Jie, Shifeng Chu, Ye Peng, et al.. (2021). Pyk2 inhibition attenuates hypoxic-ischemic brain injury in neonatal mice. Acta Pharmacologica Sinica. 43(4). 797–810. 8 indexed citations

Yang, Songwei, Shifeng Chu, Qidi Ai, et al.. (2020). Anti-inflammatory effects of higenamine (Hig) on LPS-activated mouse microglia (BV2) through NF-κB and Nrf2/HO-1 signaling pathways. International Immunopharmacology. 85. 106629–106629. 37 indexed citations

10.

Liu, Yingjiao, Shifeng Chu, Songwei Yang, et al.. (2019). Physcion and physcion 8-O-β-glucopyranoside: A review of their pharmacology, toxicities and pharmacokinetics. Chemico-Biological Interactions. 310. 108722–108722. 51 indexed citations

11.

Liu, Yingjiao, Jiao Chen, Xun Li, et al.. (2019). Research progress on adenosine in central nervous system diseases. CNS Neuroscience & Therapeutics. 25(9). 899–910. 118 indexed citations

12.

Luo, Piao, et al.. (2018). Lipid metabolism in Alzheimer’s disease. Brain Research Bulletin. 144. 68–74. 41 indexed citations

13.

Zhang, Zhao, et al.. (2018). Potential roles of brain barrier dysfunctions in the early stage of Alzheimer’s disease. Brain Research Bulletin. 142. 360–367. 7 indexed citations

14.

Ji, Xinran, Yiling Zhang, Lihai Zhang, et al.. (2016). Inhibition of p21-Activated Kinase 1 by IPA-3 Promotes Locomotor Recovery After Spinal Cord Injury in Mice. Spine. 41(11). 919–925. 1 indexed citations

15.

Xiong, Lize, Muyun Liu, Ye Peng, et al.. (2007). Shenfu injection attenuates neurotoxicity of bupivacaine in cultured mouse spinal cord neurons. Chinese Medical Journal. 120(22). 1958–1962. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact